Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a spinal pump deliver better pain relief for pancreatic cancer?

NCT ID NCT07733427

Symptom relief Sponsor: Clinique Bizet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Sep 11, 2026 · Updated 4 times

Summary

This pilot study tests whether delivering pain medication directly to the spinal cord via an implanted pump can better control severe pain in people with pancreatic cancer. The trial enrolls adults whose pain is not well managed by standard treatments or who cannot take typical painkillers. Researchers will track pain levels, opioid use, quality of life, sleep, and safety over 12 months to see if this approach offers meaningful relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intrathecal analgesia via an implantable pump delivering pain medication directly to the spinal cord
What this could lead to
If effective, this approach could offer a new way to control severe pancreatic cancer pain that does not respond to standard treatments, potentially reducing opioid use and improving quality of life.
What could go wrong
This is a small pilot study with only 40 participants, so results may not apply broadly. The procedure carries risks such as infection, bleeding, or device malfunction, and it is unclear whether it will meaningfully reduce pain or opioid needs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Subject aged over 20 years * Patient with histologically confirmed pancreatic carcinoma * Chronic cancer-related pain that is inadequately controlled by standard treatment or for whom analgesics are contraindicated. * EMO \< 120 mg/day Patients experiencing side effects: sedation, vomiting, constipation, or an allergy to morphine. * Signed informed consent * Participants affiliated with or eligible for a social security scheme * Agree to complete the various study questionnaires Exclusion Criteria: Patients under the age of 20. * Contraindications to intratracheal analgesia * Acute respiratory infection * Uncontrolled coagulation disorder * Pregnancy or breastfeeding * Unable to comply with medical follow-up for the study. * Adults who are legally protected, under guardianship or under a conservatorship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intrathecal administration of the drug are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

exocrine pancreatic carcinoma pancreatic adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intrathecal administration of the drug Intrathecal analgesic Pancreatic cancer pain Pancreatic carcinoma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Benkessou

    Paris, 75016, France

  • Bizet Clinic

    Paris, 75016, France

  • Clinique Bizet

    Paris, 75016, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.